Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Ruminococcus bromii is a keystone gut bacterium that degrades resistant starches using specialized amylosome complexes, primarily producing beneficial short-chain fatty acids, especially butyrate. These SCFAs are crucial for nourishing colonocytes and maintaining gut barrier integrity.
Reported Benefits (Provisional)
Origin & History
Ruminococcus bromii is a keystone anaerobic bacterium residing in the human colon, playing an integral role in the breakdown of resistant starches. Predominantly found in individuals consuming fiber-rich diets, it initiates the fermentation of dietary fibers, providing substrates for other gut microbes. This bacterium is critical in functional nutrition for fostering microbial diversity, enhancing metabolic regulation, and fortifying the gut barrier through short-chain fatty acid production.
Research Narrative (Provisional)
Clinical studies identify Ruminococcus bromii as a primary degrader of resistant starch, initiating downstream fermentation cascades and playing a dominant role in SCFA production. Research correlates its presence with greater microbial diversity, improved gut barrier integrity, and enhanced metabolic homeostasis.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Metabolic Output: Produces Short-Chain Fatty Acids (SCFAs) such as butyrate, propionate, and acetate. - Enzymatic Activity: Possesses enzymes capable of degrading complex resistant starches. - Substrate Utilization: Primarily utilizes resistant starches as its energy source.
Reported Mechanism (Provisional)
R. bromii utilizes cell-surface amylosome complexes, containing up to 17 amylolytic enzymes (e.g., α-amylase domains like Amy 4), to break down complex resistant starches (RS3). This enzymatic hydrolysis initiates fermentation, leading to the production of short-chain fatty acids (SCFAs) such as butyrate, propionate, and acetate. Butyrate, a primary energy source for colonocytes, enhances mucus production and strengthens tight junctions, thereby improving gut barrier integrity.
Clinical Narrative (Provisional)
Clinical studies consistently identify Ruminococcus bromii as a crucial primary degrader of resistant starch within the human colon. Its activity initiates downstream fermentation cascades, leading to significant production of short-chain fatty acids. Research further correlates the presence of R. bromii with improved gut barrier integrity, enhanced metabolic health, and greater overall microbial diversity, underscoring its keystone role in gut ecosystem balance.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.